Log in to save to my catalogue

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With...

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab5600cd5ce3499c92034282a3f1b38c

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia

About this item

Full title

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia

Publisher

Thousand Oaks: Sage Publications Ltd

Journal title

JIM - high impact case reports, 2017-02, Vol.5 (1)

Language

English

Formats

Publication information

Publisher

Thousand Oaks: Sage Publications Ltd

More information

Scope and Contents

Contents

Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient w...

Alternative Titles

Full title

Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ab5600cd5ce3499c92034282a3f1b38c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab5600cd5ce3499c92034282a3f1b38c

Other Identifiers

E-ISSN

2324-7096

DOI

10.1177/2324709617690747

How to access this item